Plain-English translation of NCT07196878 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether ultrasound-guided percutaneous neuromodulation—a minimally invasive technique that uses electrical stimulation to activate specific nerves in the leg—can help stroke survivors recover better walking ability when combined with regular physical therapy. The treatment involves using ultrasound to guide a fine needle that delivers targeted electrical pulses to nerves that control leg movement. Researchers want to see if adding this treatment to standard physical therapy produces better improvements in walking speed, leg strength, and balance than physical therapy alone.
After a stroke, many people struggle with walking and leg weakness even after months of physical therapy. While standard physical therapy is helpful, recovery is often incomplete. Researchers believe that electrical stimulation of the leg nerves might help the brain relearn how to control leg movement better, potentially giving stroke survivors an additional tool to improve their walking and independence.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the new nerve stimulation treatment plus physical therapy, or physical therapy alone. Those receiving the nerve stimulation treatment will have several sessions where a thin needle delivers electrical pulses to leg nerves under ultrasound guidance—each stimulation lasts about 10 seconds with short rest breaks. All participants will continue with their regular physical therapy. The trial will measure changes in your walking speed, leg strength, balance, and ability to move around in daily life.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
Spain